Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Eytan Raz

Neuroradiology New York, NY Medical Doctor

NPI 1972883155 CMS profile 43937

550 1St Ave, New York, NY 10016

Open in the dashboard

General payments

$605,142

717 records reported · program years 2019–2025

Research payments

$2,461

Paid to them · 4 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$150,318 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Eytan Raz of New York, NY is reported in the CMS Open Payments database as having received $605,142 across 717 general payments and $2,461 in research payments paid to them. Separately, studies naming them as principal investigator received $150,318 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Neuroradiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $260,004 272
2025 Research $2,000 2
2024 General $146,356 172
2023 General $99,118 107
2022 General $82,431 76
2022 Research $461 2
2021 General $5,991 28
2020 General $695 25
2019 General $10,546 37

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eytan Raz
  • Neuroradiology median
  • Middle half of Neuroradiology
  • National median

In program year 2025, general payments to Eytan Raz were reported at $260,004. Among 399 Neuroradiology profiles paid that year, the median was $279 and the middle half received between $65 and $2,205.

Show as a table
Year Eytan Raz Neuroradiology median Middle half National median
2019 $10,546 $288 $71–$2,035 $163
2020 $695 $165 $32–$1,794 $114
2021 $5,991 $238 $42–$1,807 $132
2022 $82,431 $191 $49–$1,388 $149
2023 $99,118 $228 $56–$1,148 $160
2024 $146,356 $241 $97–$2,192 $164
2025 $260,004 $279 $65–$2,205 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. MicroVention, Inc. $312,432 358 payments
  2. Medical Device Business Services, Inc. $95,530 81 payments
  3. Balt USA, LLC $68,815 23 payments
  4. Imperative Care, INc $30,071 35 payments
  5. Medtronic, Inc. $29,113 106 payments
  6. Qapel Medical Inc $23,590 5 payments
  7. Siemens Medical Solutions USA, Inc. $12,962 7 payments
  8. Route 92 Medical, Inc. $10,722 8 payments
  9. Rapid Medical LTD $7,837 3 payments
  10. Baylis Medical Technologies Inc. $4,600 1 payment
  11. Other $9,470 90 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $237,313 118 payments
  2. Consulting Fee $222,627 57 payments
  3. Travel and Lodging $117,878 244 payments
  4. Food and Beverage $21,321 296 payments
  5. Education $6,000 1 payment
  6. Gift $4 1 payment
Products named General payments · program years 2019–2025
  1. WEB ANEURYSM EMBOLIZATION SYSTEM $303,642 335 payments
  2. EMBOGUARD $85,524 37 payments
  3. ZOOM 88-T LARGE DISTAL PLATFORM $25,084 18 payments
  4. Pipeline $23,214 53 payments
  5. Comaneci $7,715 2 payments
  6. Optima Coil System $6,950 7 payments
  7. HYBRID Guidewire $6,140 2 payments
  8. Ballast 088 Long Sheath $6,140 2 payments
  9. Prestige Coil System $6,140 2 payments
  10. Zoom88LargeDistalPlatform $4,733 13 payments
  11. Other $56,814 352 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $2,000 2 payments
  2. Rapid Medical LTD $461 2 payments

Billing to Medicare

Part B · data year 2024 · 98 billing codes

Paid by Medicare

$130,786

Of which drugs: $1,310

Medicare patients

1,082

Average age 77

Services billed

6,988

633 women, 449 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 69%
Ischemic heart disease 52%
Diabetes 45%
Chronic kidney disease 45%
Depression 39%
Heart failure 37%
Atrial fibrillation 34%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, gadobutrol, 0.1 ml A9585 Office 61 5,150 $1,304

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

721 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neuroradiology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record